Phase 1 Trial Initiated with Data Expected in the First Half of 2025 Friedreich Ataxia (FA) Program on Track to Initiate Phase 1 Single Ascending Dose, Healthy Volunteer Study in the First Half of ...

In men, the association was not statistically significant. Researchers explained that systemic inflammation, oxidative stress ...

Cardiovascular Health NR may benefit cardiovascular health by improving mitochondrial function and reducing oxidative stress.